Longevity & AgingExpanding Treatments Offer New Options for Dermatomyositis
Dermatomyositis treatment is expanding, offering more options for an autoimmune disease that can inflame skin and weaken muscles. A specialist discussion reported by MedPage Today describes how doctors combine sun protection and topical steroids with medications that control immune activity. Intravenous immunoglobulin, an approved treatment supported by a trial focused on muscle disease, also improved skin symptoms in some participants. Treatment choices depend on which symptoms dominate, whether cancer is involved, and how patients respond over time. The report highlights caution with JAK inhibitors in patients with cancer and the importance of reducing oral steroids when clinically appropriate. These are specialist treatment decisions, not general longevity interventions. The supplied article is incomplete and provides expert commentary rather than detailed comparisons of treatment effectiveness or safety.
